Skip to main content

Table 3 Number of immunoreactive linear epitopes identified in human EBOV (1:12,800) and BOMV (1:800) reactive serum samples compared to a negative human serum sample by gene and overall for all six ebolaviruses and Marburg virus

From: Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak

 

EBOV Presumptive Positive Patient

BOMV Presumptive Positive Patient

Negative Human

Peptide

NP

VP35

VP40

GP

VP30

VP24

L

Tot

NP

VP35

VP40

GP

VP30

VP24

L

Tot

NP

VP35

VP40

GP

VP30

VP24

L

Tot

EBOV

2

 

1

3

  

3

9

9

 

4

10

4

 

16

43

        

BOMV

4

  

2

1

 

4

11

10

6

3

10

3

2

18

52

 

1

 

1

  

1

3

SUDV

   

1

 

1

2

4

8

 

1

12

5

 

16

42

   

1

  

1

2

BDBV

2

  

3

1

 

4

10

7

 

1

10

2

 

15

35

        

TAFV

3

   

1

 

2

6

9

 

3

10

2

 

18

42

        

REST

3

  

2

  

4

9

9

  

11

3

 

18

41

2

  

3

   

5

MARV

2

     

1

3

9

 

4

13

3

 

22

51

   

2

1

  

3